Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:16:59 EDT Mon 03 Aug 2026
Enter Symbol
or Name
USA
CA



Q:ELTP - ELITE PHARMACEUTICALS INC - https://www.elitepharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ELTP - Qnot subscribed0.3716-0.0073-1.9253.7891250.3789  0.379  0.357150.74  0.325215:59:53Jun 2915 min RT 2¢

Recent Trades - Last 10 of 125
Time ETExPriceChangeVolume
15:59:53Q0.3716-0.00732,501
15:59:34Q0.375-0.003910,000
15:59:27Q0.3716-0.0073250
15:59:25Q0.375-0.00399,800
15:59:24Q0.375-0.00392,500
15:59:17Q0.3699-0.009200
15:58:45Q0.3733-0.0056200
15:58:03Q0.3716-0.0073100
15:57:47Q0.3733-0.0056200
15:55:01Q0.3682-0.01071,500

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-06-29 16:30U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2026 and Provides Conference Call Information
2026-06-23 07:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2026 Financial Results on June 30, 2026
2026-06-15 07:01U:ELTPNews ReleaseElite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
2026-06-01 07:02U:ELTPNews ReleaseElite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product
2026-04-02 08:01U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets
2026-02-17 16:20U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information
2026-02-11 16:31U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026
2025-11-14 16:20U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information
2025-11-12 07:02U:ELTPNews ReleaseElite Pharmaceuticals Receives FDA Approval for Generic Requip XL(R)
2025-11-10 07:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025
2025-08-14 16:26U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2026 ended June 30, 2025 and Provides Conference Call Information
2025-08-08 16:31U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2026 Financial Results on August 15, 2025